24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Fitch
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:38
Who will cover the damages of the largest computer failure in history?
16:00
Scopio Labs secures $42 million Series D for AI-based blood cell analysis
14:47
"Growing high-tech is essential for the economy of the North"
14:31
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
2
JPMorgan CEO Jamie Dimon makes whirlwind visit to Israel
3
From IPO dreams to CrowdStrike’s crisis: Inside the collapse of the Wiz-Google mega deal
4
Israel’s Quantum Transistors receives €17.5M from the European Innovation Council for its quantum computing solution
5
Amdocs set to cut 1,500-3,000 jobs in new round of layoffs
More news
Fitch
6 stories about Fitch
Fitch reaffirms Israel's A+ rating, removes Negative Watch
02.04.24
|
Reuters
Fitch ratings' outlook for Israel remains negative to "reflect the combination of uncertainties around the fiscal trajectory and the war's duration and intensity, including the risk of regional escalation."
Fitch Affirms Israel’s A+ Rating, Citing Strong Growth
01.09.19
|
Omri Milman
The credit rating agency affirmed the rating with a stable outlook, estimating the deficit will grow to 3.6% of GDP in 2019, in line with the forecasts of the Israeli Ministry of Finance
Fitch Downgrades Teva, Keeps Outlook at Negative
10.06.19
|
Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
High Government Debt Countered by Strong Finances Leads Fitch to Affirm Israel's A+ Rating
26.03.19
|
Lilach Baumer
Israel scores above the median on GDP growth and human development indicators, but low on government budget deficit, government debt, and ease of doing business
JPMorgan Downgrades Teva’s Stock to Underweight
13.11.17
|
Amarelle Wenkert
Christopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit
Fitch Downgrades Teva to Junk Rating
07.11.17
|
Yaniv Rahimi
The U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt
Please ensure Javascript is enabled for purposes of
website accessibility